Home > News > The Week in Innovation
November 14th, 2007
The Week in Innovation
Abstract:
A number of companies have made serious headway in applying nanotechnology to improve existing products -- such as DuPont (NYSE: DD) in the field of thermoplastics. Well, this week two more interesting innovations in carbon nanotubes research could soon work their way into the marketplace.
Researchers at the University of Texas have demonstrated that cancer cells can be destroyed by injecting carbon nanotubes directly into them and then zapping them with radio frequency waves. The frequency of the radiation can be controlled to leave the rest of the body undamaged. In other words, the days of current chemotherapy, which kills both bad and good cells, could be numbered.
At the University of California at Berkeley, researchers have fashioned the world's tiniest radio out of carbon nanotubes. Now, this device isn't the kind of radio you can listen to in your car, but in combination with microelectromechanical sensors (which measure blood sugar levels or identify cancer markers in the body) it could provide wireless communication between those sensors and an external monitor.
Source:
fool.com
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||